Table 1 |
||
|
Baseline data from 250 female and male overweight and obese participants |
||
|
Parameter |
Evaluable N1 |
Mean(SD) |
|
|
||
|
Age (y) |
243 |
47.6(11.6) |
|
Weight (kg) |
243 |
97.3(18.2) |
|
Height (cm) |
243 |
166(8) |
|
Body mass index (kg/m2) |
243 |
35.4(5.2) |
|
Body fat (%) |
243 |
38.2(6.6) |
|
2Waist (cm) |
243 |
100.4(12.8) |
|
2Systolic blood pressure (mmHg) |
243 |
123(18) |
|
2Diastolic blood pressure (mmHg) |
243 |
70(10) |
|
2Triglyceride (mmol/L) |
243 |
1.56(0.82) |
|
2High density lipoprotein-cholesterol (mmol/L) |
243 |
1.33(0.34) |
|
2Fasting plasma glucose (mmol/L) |
234 |
5.32(1.38) |
|
Haemoglobin A1c (%) |
217 |
5.25(0.82) |
|
2Metabolic syndrome marker count |
234 |
2.4(1.1) |
|
Vitamin D3nmol/L* |
||
|
Total |
243 |
62.2(22.7) |
|
Women |
200 |
62.4(21.9) |
|
Men |
43 |
61.7(26.3) |
|
Skin pigment, light |
206 |
64.8(22.0) |
|
Skin pigment, variable |
37 |
47.5(20.0) |
|
Summer |
141 |
68.7(21.9) |
|
Winter |
102 |
53.3(20.6) |
|
2Metabolic syndrome, no |
135 |
61.4(22.8) |
|
2Metabolic syndrome, yes |
99 |
63.8(22.4) |
|
Non-type II diabetes mellitus |
223 |
62.7(22.7) |
|
Type II diabetes mellitus |
11 |
55.5(20.1) |
|
|
||
|
* Raw data in pair sets. See text for multivariable regression results. 1Although anthropometry was collected on all 250 participants, data is only shown for 243, as evaluable serum samples for vitamin D3 analysis were available for this number (N) only. 6 samples were not obtained due to unsuccessful venepuncture and 1 sample was lost in transit to the laboratory. For the sub-groups some samples were not evaluable due to sample quality or loss. Sample number (N) is shown for each category. 2 Metabolic syndrome (N=234) is defined by the International Diabetes Federation as 1) Waist circumference: Europids and Undefined groups [such as Maori and Pacific Peoples] ≥ 94 cm (men), ≥ 80 cm (women), Asian (based on a Chinese, Malay and Indian Asian population) ≥ 90 cm (men) and ≥ 80 cm (women). Waist must be included, plus two or more of 2) Systolic and diastolic blood pressure ≥ 130/85 mmHg, 3) High density lipoprotein – cholesterol <1.03 mmol/L (<40 mg/dL) men, <1.29 mmol/L (<50 mg/dL) women 4) Triglyceride ≥ 1.69 mmol/L (150 mg/dL) 5) Fasting plasma glucose ≥ 5.6 mmol/L (≥ 100 mg/dL) and/or on treatment medication for the latter 4 conditions. |
||
|
McGill et al. Nutrition Journal 2008 7:4 doi:10.1186/1475-2891-7-4 |
||
